Bifogade filer
Kurs
-1,88%
Likviditet
34,6 MSEK
Kalender
Tid* | ||
2026-02-02 | 08:00 | Bokslutskommuniké 2025 |
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-15 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-08 | - | Årsstämma |
2025-04-25 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-05 | 08:00 | Bokslutskommuniké 2024 |
2024-10-23 | - | Kvartalsrapport 2024-Q3 |
2024-07-15 | - | Kvartalsrapport 2024-Q2 |
2024-05-10 | - | X-dag ordinarie utdelning ALIF B 0.50 SEK |
2024-05-08 | - | Årsstämma |
2024-04-24 | - | Kvartalsrapport 2024-Q1 |
2024-02-02 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-07-14 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | X-dag ordinarie utdelning ALIF B 1.20 SEK |
2023-05-04 | - | Årsstämma |
2023-04-26 | - | Kvartalsrapport 2023-Q1 |
2023-02-02 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-07-15 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning ALIF B 2.00 SEK |
2022-05-05 | - | Årsstämma |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-02-04 | - | Bokslutskommuniké 2021 |
2021-10-22 | - | Kvartalsrapport 2021-Q3 |
2021-07-15 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | X-dag ordinarie utdelning ALIF B 1.50 SEK |
2021-05-05 | - | Årsstämma |
2021-04-28 | - | Kvartalsrapport 2021-Q1 |
2021-02-03 | - | Bokslutskommuniké 2020 |
2020-11-20 | - | X-dag bonusutdelning ALIF B 0.5 |
2020-11-19 | - | Extra Bolagsstämma 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-07-17 | - | Kvartalsrapport 2020-Q2 |
2020-05-27 | - | Split ALIF B 1:4 |
2020-05-08 | - | X-dag ordinarie utdelning ALIF B 0.00 SEK |
2020-05-07 | - | Årsstämma |
2020-04-28 | - | Kvartalsrapport 2020-Q1 |
2020-02-06 | - | Bokslutskommuniké 2019 |
2019-11-07 | - | Kvartalsrapport 2019-Q3 |
2019-07-12 | - | Kvartalsrapport 2019-Q2 |
2019-05-10 | - | X-dag ordinarie utdelning ALIF B 2.20 SEK |
2019-05-09 | - | Årsstämma |
2019-05-09 | - | Kvartalsrapport 2019-Q1 |
2019-02-12 | - | Bokslutskommuniké 2018 |
2018-12-20 | - | Extra Bolagsstämma 2018 |
2018-11-07 | - | Kvartalsrapport 2018-Q3 |
2018-07-13 | - | Kvartalsrapport 2018-Q2 |
2018-06-01 | - | X-dag ordinarie utdelning ALIF B 2.20 SEK |
2018-05-31 | - | Årsstämma |
2018-04-27 | - | Kvartalsrapport 2018-Q1 |
2018-02-13 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-07-17 | - | Kvartalsrapport 2017-Q2 |
2017-05-30 | - | X-dag ordinarie utdelning ALIF B 1.50 SEK |
2017-05-29 | - | Årsstämma |
2017-04-28 | - | Kvartalsrapport 2017-Q1 |
2017-02-16 | - | Bokslutskommuniké 2016 |
2016-10-27 | - | Kvartalsrapport 2016-Q3 |
2016-09-02 | - | X-dag ordinarie utdelning ALIF B 0.00 SEK |
2016-09-01 | - | Årsstämma |
2016-07-15 | - | Kvartalsrapport 2016-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | Large Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
According to AddLife AB, org. no. 556995-8126, ("AddLife") Articles of Association, the owner of Class A shares has the right to request that the share be converted into Class B shares. At the request of shareholders, 37,000 Class A shares were converted to 37,000 Class B shares.
Following the conversion, the total number of shares and votes in AddLife as of October 31, 2024, amounts to 122,450,250 shares and 163,605,414 votes, respectively. 4,572,796 of these shares are Class A shares, representing 45,727,960 votes, and 117,877,454 are Class B shares, representing 117,877,454 votes. AddLife's share capital and the share's quota value are unchanged.
For more information, contact;
Fredrik Dalborg, CEO, fredrik.dalborg@add.life,+46 70 516 09 01
Christina Rubenhag, CFO, christina.rubenhag@add.life,+46 70 546 72 22
www.add.life
AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has about 2,300 employees in some 85 operating subsidiaries. The Group currently has net sales of more than SEK 10 billion. AddLife shares are listed on Nasdaq Stockholm.
This information is information that AddLife AB is obliged to make public pursuant to the Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact persons set out above, on October 31, 2024, at 2.00 p.m (CET).